C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
Jeffrey A. Kern, David A. Schwartz(Perinatal Institute), Donna J. Lager(Mayo Clinic), Robert A. Robinson(University of Iowa Hospitals and Clinics), Sjoerd Rodenhuis(The Netherlands Cancer Institute), Robbert J.C. Slebos(University of Iowa), Bert Top(University of Iowa), David B. Weiner(The Wistar Institute)
Cited by 181
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Proteogenomic characterization of human colon and rectal cancer
|Nature|2014|1.6k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
|Cell Metabolism|2012|1.1k
Toll-like Receptor 4 Polymorphisms and Atherogenesis
|New England Journal of Medicine|2002|1k